7:51 am Teva Pharma receives CHMP positive opinion for DuoResp Spiromax for the treatment of patients diagnosed with asthma and COPD in Europe

7:51 am Teva Pharma receives CHMP positive opinion for DuoResp Spiromax for the treatment of patients diagnosed with asthma and COPD in Europe

more

View todays social media effects on TEVA

View the latest stocks trending across Twitter. Click to view dashboard

See who Teva is hiring next, click here to view

Share this post